Login to Your Account

NewCo News

Avillion Gets Initial Funding, Helps Pharma Pick Up Pace

By Nuala Moran
Staff Writer

Wednesday, January 30, 2013
Pharma's productivity woes have spawned a new UK company, Avillion LLP, which is offering to plug between $50 million and $100 million into the co-development of Phase III assets.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription